Cargando…
Neuroprotective Effects of Higenamine Against the Alzheimer’s Disease Via Amelioration of Cognitive Impairment, Aβ Burden, Apoptosis and Regulation of Akt/GSK3β Signaling Pathway
The present investigation was envisaged to elucidate the neuroprotective effect of Higenamine (HGN) against aluminum chloride (AlCl(3)) triggered experimental Alzheimer’s disease (AD) rat model. Thirty-six male albino Wister rats were randomized and divided in 6 groups and subjected to experimentati...
Autores principales: | Yang, Xiaona, Du, Wanliang, Zhang, Yun, Wang, Hui, He, Maolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734528/ https://www.ncbi.nlm.nih.gov/pubmed/33354171 http://dx.doi.org/10.1177/1559325820972205 |
Ejemplares similares
-
β(2)‐Adrenoceptor agonist activity of higenamine
por: Hudzik, Thomas J., et al.
Publicado: (2021) -
Aerobic Exercise Regulates Apoptosis through the PI3K/Akt/GSK-3β Signaling Pathway to Improve Cognitive Impairment in Alzheimer's Disease Mice
por: Peng, Yan, et al.
Publicado: (2022) -
PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse
por: Zhou, Xing-qin, et al.
Publicado: (2018) -
Higenamine inhibits IL-1β-induced inflammation in human nucleus pulposus cells
por: Bai, Xiaoliang, et al.
Publicado: (2019) -
AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016)